CBB
CLVS

Citizens Business Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

Citizens Business Bank’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,000
Closed -$33K – 261
2021
Q4 		$33K Buy
+12,000
New +$44.4K ﹤0.01% 250

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Citizens Business Bank's CLVS Position: Q1 2022 in Review

Citizens Business Bank sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 12,000 shares — an estimated $33K sold.

Citizens Business Bank first reported a position in CLVS in Q4 2021 and held it in 1 quarter. The position peaked at $33K in Q4 2021. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Citizens Business Bank reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Citizens Business Bank sold 12,000 Clovis Oncology, Inc. shares in Q1 2022, an estimated $33K.
  • Citizens Business Bank first reported a position in Clovis Oncology, Inc. in Q4 2021 and held it in 1 quarter.
  • Citizens Business Bank's Clovis Oncology, Inc. position peaked at $33K in Q4 2021.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Citizens Business Bank's 13F filing for Q1 2022, filed 18 Nov 2022.